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The patient was a 71-year-old man with an abnormal shadow on chest X-ray.  Computed 
tomography (CT) of the chest showed a tumor of 38 mm in size in the upper lobe of the 
left lung S3.  A CT-guided lung biopsy was performed, but no malignancy was observed. 
18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) revealed a high 
FDG uptake in the tumor:  the maximum and mean values of the standard FDG uptake 
in the early phase were 7.3 and 5.3, respectively, and those in the latter phase, 8.3 and 
5.9, respectively.  The hilar and mediastinal lymph nodes also showed positive for high 
FDG uptakes.  We strongly suspected lung cancer, and performed a left upper lobecto-
my by video-assisted thoracic surgery.  The pathological diagnosis was an inflammatory 
pseudotumor of the lung:  it is a rare disease but often requires differentiation from lung 
cancer.  Literature has been few on FDG-PET about inflammatory pseudotumor of the 
lung.  Differentiation of the disease from lung cancer was especially difficult in the pres-
ent patient, because both lymph nodes and the tumor showed high FDG uptakes.
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Inflammatory pseudotumor of the lung has been 
more frequently detected due to the recent progress 
in diagnostic imaging, but it is difficult to differen-
tiate from lung cancer. In many patients, the diag-
nosis is confirmed with surgery.  We have encoun-
tered a male patient highly suspected of lung can-
cer due to his high uptake of 18F-fluorodeoxyglu-
cose (FDG) in FDG-positron emission tomography 
(PET).  We diagnosed his disease as inflammatory 
pseudotumor of the lung via video-assisted thoracic 
surgery.  Few literature focuses on FDG-PET and 
inflammatory pseudotumor of the lung.  The pres-
ent patient showed a high FDG uptake also in the 
lymph node, which made us confused in differenti-
ating from lung cancer.  We herein present the case 
of our patient, with bibliographical considerations 
as well.
 
Patient Report
 
This 71-year-old man had undergone medical ex-
aminations every year, but no abnormalities were 
detected.  In July 2007, he had general fatigue and 
hemosputum, and visited nearby hospital where an 
abnormal shadow in the left upper lung was found 
on examination.  He was referred to our Univer-
sity Hospital.  Laboratory findings at the time of 
admission were a white blood cell count of 6,100/
μL without any left shift of the nucleus, and the 
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C-reactive protein level of 0.52 mg/dL.  General or 
biochemical examinations of the blood showed no 
other abnormalities, and all of the tumor markers 
were negative.  Chest X-ray showed a nodular den-
sity with approximately 40 mm in size in the left 
upper lung (Fig. 1).  Chest computed tomography 
(CT) visualized a 38 × 32 mm tumor in size hav-
ing broad contact with the parietal pleura in the left 
upper lobe S3 (Fig. 2). The periphery of the tumor 
was irregular, and the boundary was relatively 
well defined.  Lymph nodes were enlarged at both 
the hilar and the mediastinal regions.  In FDG-
PET (Fig. 3), we observed a high FDG uptake just 
matching the tumor.  The maximum and mean 
values of the standard FDG uptake in the early 
phase were 7.3 and 5.3, respectively, and those in 
the latter phase, 8.3 and 5.9, respectively.  In ad-
dition, high FDG uptake was also observed in 
both the hilar and the mediastinal regions, so lung 
Fig. 1.  Chest X-ray showed an irregular-circumscribed 
abnormal shadow in the left middle field of the lung.
cancer and metastases to the lymph nodes were 
strongly suspected.  The CT-guided lung biopsy 
resulted in nonspecific inflammatory findings, and 
no malignant cells were observed.  However, on 
considering FDG-PET findings, lung cancer could 
not be ruled out.  Therefore, thoracoscopic surgery 
was performed after obtaining informed consent 
from the patient.  The tumor had firmly adhered to 
the parietal pleura, and a needle biopsy exhibited 
no malignant cells on pathological tissues frozen 
intraoperatively.  We suspected an inflammatory 
pseudotumor, and performed a simple left upper 
lobectomy by video-assisted thoracic surgery.  The 
resected tumor (Fig. 4) was 38 × 32 mm in size, 
sectionally xanthochromatic with mild anthraco-
sis.  Its shape was relatively regular in the periph-
ery, well defined, solid and elastically soft.  In the 
pathological tissue (Fig. 5), we found a lesion that 
was mainly comprised of organized pneumonic fi-
brosis, with inflammatory cell infiltration involving 
lymphocytes and plasma cells.  When the image of 
the area was enlarged on the monitor, we observed 
inflammatory cells, fibrosis and spindle-shaped 
mesenchymal cells, which led us to the diagnosis 
of inflammatory pseudotumor, fibrous histiocytic 
type of the lung.  The patient’s postoperative course 
was good, and no recurrence has been observed.
  
Fig. 3.  FDG-PET revealed a high FDG uptake just 
matching the tumor, the hilar and mediastinal lymph 
nodes (arrows). FDG, 18F-fluorodeoxyglucose; PET, posi-
tron emission tomography.
Fig. 2.  Chest CT revealed an irregular tumor, 38  32 
mm in size, having broad contact with the parietal pleura 
in the left upper lobe S3. CT, computed tomography. 
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Fig. 5.  Pathological findings showed inflammatory cell infiltration involving lymphocytes and plasma cells, fibrosis 
and spindle-shaped mesenchymal cells with hematoxylin and eosin staining of low power field (A) and high power 
field (B).  Bar = 500 µm in A and 50 µm in B.
Fig. 4.  The resected tumor (arrow) in the left upper lobe was 38  32 mm in 
size with a relatively regular margin and a solid and elastically soft interior.  A: 
Left upper lobe.  B: A cut surface of the tumor.
 
Discussion
 
Inflammatory pseudotumor of the lung is a 
solitary, non-neoplastic, space-occupying lesion 
in which collagenic fiber, inflammatory cells and 
mesenchymal cells are blended together in various 
amounts (Bernardi et al., 1983).  In 2000, Cerfolio 
et al. reported that among 56,400 patients treated 
with chest surgery over 50 years at the Mayo 
Clinic, inflammatory pseudotumor of the lung was 
observed in only 23 patients (0.04%), of which 18 
patients (78%) were involved with symptoms such 
as coughing, hemosputum, shortness of breath 
and chest pain (Cerfolio et al., 2000).  In imaging 
modalities, the pseudotumor is seen as an isolated 
and well-defined shadow with a round to oval 
shape, and clinical differentiation from lung cancer 
is often difficult (Ishida et al., 1989; Kobashi et al., 
2006).  In the present patient as well, we suspected 
lung cancer from the clinical symptoms and image 
findings, and performed the CT-guided lung biopsy, 
but no malignant cells were observed.  However, 
FDG-PET of the tumor further showed a high FDG 
uptake, so we highly suspected lung cancer again 
and considered performing video-assisted thoracic 
surgery.  Recently, FDG-PET has been widely 
used as an adjunct for the diagnosis of lung cancer 
(Ung et al., 2007).  A higher level of the standard 
FDG uptake is correlated to poorer prognosis 
A
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(Berghmans et al., 2008).  However, FDG-PET 
often shows positive even for inflammatory lung 
disease.  Of 66 patients with lung nodule shadows 
that were positive in FDG-PET, 7 patients were 
false positive for inflammatory lung disease:  one 
of the 7 had an inflammatory pseudotumor of the 
lung (Higashi et al., 2001).  Because inflammatory 
pseudotumor of the lung is a rare disease, 
application of FDG-PET has been seldom reported 
(Slosman et al., 1994).  But, FDG-PET shows high 
FDG uptake for inflammatory pseudotumor of the 
lung, and differentiation from liver cancer or lung 
cancer is difficult (Kawashima et al., 2006).  In 
addition, it is characteristic of FDG-PET that the 
hilar and the mediastinal lymph nodes also show 
positive, as observed in the present patient.  FDG-
PET is also useful in diagnosing metastasis of 
lung cancer to lymph nodes (Melek et al., 2008), 
which makes differentiation of lung pseudotumor 
from lung cancer more difficult.  Even though 
inflammatory pseudotumor of the lung is benign, 
3 of 5 patients with incomplete resection had a 
recurrence (Cerfolio et al., 2000), or 3 of 18 treated 
patients had a recurrence (Melloni et al., 2005). 
Therefore, we had no choice but to perform a left 
upper lobectomy in the present patient, because 
sufficient resection margins are required.  The 
postoperative course was good, and we believe that 
this was an appropriate choice.  Cases of recurrence 
after complete resection have been reported 
(Dehabreh et al., 1999) with some multiple tumor 
cases (Lee et al., 2005; Kobashi et al., 2006).  We 
emphasize that the present patient will require 
a careful follow-up.  Along with the progress in 
diagnostic imaging, inflammatory pseudotumor 
of the lung has been increasingly observed.  The 
characteristics of FDG-PET findings should also 
be fully understood. 
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